L-Isoleucine (JP14/USP)
L-Isoleucine (JP14/USP) Brand names, L-Isoleucine (JP14/USP) Analogs
- (2S,3S)-2-Amino-3-methylpentanoic acid
- (2S,3S)-a-Amino-b-methyl-n-valeric acid
- (2S,3S)-a-Amino-b-methylvaleric acid
- (S)-Isoleucine
- (S,S)-Isoleucine
- 2-Amino-3-methylvaleric acid
- 2S,3S-Isoleucine
- Isoleucine
- Isoleucine, L-
- L-(+)-Isoleucine
- L-Ile
- L-Isoleucine
- L-Isoleucine (JP14/USP)
- L-Norvaline, 3-methyl-, erythro-
- Pentanoic acid, 2-amino-3-methyl-, (2S,3S)-
- [S-(R*,R*)]-2-Amino-3-methylpentanoic acid
- erythro-L-Isoleucine
L-Isoleucine (JP14/USP) Brand Names Mixture
- No information avaliable
L-Isoleucine (JP14/USP) Chemical_Formula
C6H13N1O2
L-Isoleucine (JP14/USP) RX_link
No information avaliable
L-Isoleucine (JP14/USP) fda sheet
L-Isoleucine (JP14/USP) msds (material safety sheet)
L-Isoleucine (JP14/USP) Synthesis Reference
No information avaliable
L-Isoleucine (JP14/USP) Molecular Weight
131.174 g/mol
L-Isoleucine (JP14/USP) Melting Point
168-170 oC
L-Isoleucine (JP14/USP) H2O Solubility
No information avaliable
L-Isoleucine (JP14/USP) State
Solid
L-Isoleucine (JP14/USP) LogP
-1.743
L-Isoleucine (JP14/USP) Dosage Forms
Capsules, powder, tablets
L-Isoleucine (JP14/USP) Indication
The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.
L-Isoleucine (JP14/USP) Pharmacology
They provide ingredients for the manufacturing of other essential biochemical components in the body, some of which are utilized for the production of energy, stimulants to the upper brain and helping you to be more alert.
L-Isoleucine (JP14/USP) Absorption
Absorbed from the small intestine by a sodium-dependent active-transport process
L-Isoleucine (JP14/USP) side effects and Toxicity
Symptoms of hypoglycemia, increased mortality in ALS patients taking large doses of BCAAs
L-Isoleucine (JP14/USP) Patient Information
No information avaliable
L-Isoleucine (JP14/USP) Organisms Affected
Humans and other mammals
